Migliavacca, M. Et Al. 2024. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.. Nature medicine .

Migliavacca, M., Barzaghi, F., Fossati, C., Rancoita, P. M. V., Gabaldo, M., Dionisio, F., ... Giannelli, S.(2024). Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.. Nature medicine .

Migliavacca, Maddalena Et Al. "Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.," Nature medicine , 2024

Migliavacca, Maddalena Et Al. "Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.." Nature medicine , 2024

Migliavacca, M. Et Al. (2024) . "Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.." Nature medicine .

@article{article, author={Maddalena Migliavacca Et Al. }, title={Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.}, journal={Nature medicine}, year=2024}